Ultromics granted FDA Breakthrough Device Status
Ultromics has gained FDA Breakthrough Device Designation for its AI-powered EchoGo Amyloidosis platform, which is speeding up diagnosis.
Back to Top
Ultromics has gained FDA Breakthrough Device Designation for its AI-powered EchoGo Amyloidosis platform, which is speeding up diagnosis.
AI-driven predictive analytics can help the heaviest users of health services to self-care and save the NHS from disaster, says HN’s Joachim Werr.
AI could help doctors diagnose lung cancer earlier, according to a study led by researchers from The Royal Marsden NHS Foundation Trust.
Suffolk Primary Care has partnered with Aide Health for a 12-month programme to support patients with asthma and stop the overuse of reliever inhalers. Â
Health Navigator Ltd (HN) has committed its feasibility study into its AI-Guided Clinical Coaching (AICC) programme into an investment fund for NHS trusts.
Monitoring apps are increasingly popular as more elderly people and those with disabilities seek to remain in their homes. Â